Therefore, we assessed the malignant potential of HERC5 loss in in vitro and in vivo NSCLC models and demonstrated its capacity to transform NSCLC cells both in vitro and in vivo into a more aggressive phenotype. Here, HERC5 is linked to non-small cell lung carcinoma.